Author

Hori Tomoki

Sapporo Medical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Atsushi KunoiD· 1 shared Iyori Nojima· 1 shared Keiji SaitoiD· 1 shared Koki AbeiD· 1 shared Ryo NumazawaiD· 1 shared Ryusuke HosodaiD· 1 shared Tatsuya SatoiD· 1 shared Yuki TatekoshiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Atsushi KunoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Activation of the NAD⁺-Sirtuin Axis Protects Against Chronic Doxorubicin-Induced Subclinical Renal Tubular Injury Through Restoration of Mitochondrial Homeostasis and Suppression of Inflammation

Keiji Saito, Ryusuke Hosoda, Ryo Numazawa, Hori Tomoki, Iyori Nojima, Yukika Saga, Yuki Tatekoshi, Tatsuya Sato, Koki Abe, Atsushi Kuno

This study shows that chronic low-dose doxorubicin causes mitochondrial dysfunction and inflammation in renal tubules, which can be mitigated by activating the NAD⁺-Sirtuin axis with resveratrol or NMN.

bioRxiv · Aug 3, 2026 · PreprintPharmacology & Toxicology